It is always a difficult decision to temporarily close a gold mine down ..in this case Zoono for a couple of weeks to be able to streamline your operations and put in place protocols and procedures to deal with the frenetic expansion that has taken place and clear the backlog of sales ...growing pains. To be able to operate 2 distribution points for B2B and B2C from scratch is immense , Let alone all the other distributors and new online sales approaches going forward. Rather be in this situation going forward than no sales and no business and being forced to close down.
Alas, This may turn out to be another A2 scenario company with exponential sales going forward once we progress through the current nightmare. One thing is becoming evident form previous posts and research on line is that the key ingredient being used by Zoono will also, from early trials, be part of the cure being Hydroxychloroquine.
As for sales this quarter from their own estimates of 15 million Plus ........ dont be surprised if they exceed these by a big margin and for the next quarter at least double IMHO.
DYOR and GLYALH
ZNO Price at posting:
$1.27 Sentiment: Buy Disclosure: Held
